Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kalbe Farma | Jakarta | Salute | Prodotti farmaceutici | 56,30 Bln IDR | 18,3x | 3,73 | 1.220 IDR | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 43,4% Rialzo | Fai l’upgrade a Pro+ | |
Jamu dan Farmasi Sido | Jakarta | Salute | Prodotti farmaceutici | 17,10 Bln IDR | 15x | 0,85 | 570 IDR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29,4% Rialzo | Fai l’upgrade a Pro+ | |
Tempo Scan Pacific | Jakarta | Salute | Prodotti farmaceutici | 11,14 Bln IDR | 8,5x | -1,17 | 2.470 IDR | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Soho Global | Jakarta | Salute | Prodotti farmaceutici | 8,38 Bln IDR | 19,1x | 0,62 | 660 IDR | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Enseval Putra | Jakarta | Salute | Prodotti farmaceutici | 6,20 Bln IDR | 8,4x | 3,14 | 2.290 IDR | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pyridam Farma | Jakarta | Salute | Prodotti farmaceutici | 2,43 Bln IDR | -7,5x | -0,13 | 216 IDR | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Darya-Varia | Jakarta | Salute | Prodotti farmaceutici | 1,90 Bln IDR | 9,8x | 0,07 | 1.695 IDR | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Jakarta | Salute | Prodotti farmaceutici | 1,57 Bln IDR | 12,6x | -0,56 | 3.510 IDR | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Penta Valent PT | Jakarta | Salute | Prodotti farmaceutici | 540,28 Mrd IDR | 11,6x | 0,46 | 306 IDR | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ikapharmindo Putramas PT | Jakarta | Salute | Prodotti farmaceutici | 444,75 Mrd IDR | 26,8x | 264 IDR | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Indofarma | Jakarta | Salute | Prodotti farmaceutici | 390,51 Mrd IDR | -0,6x | 0,01 | 126 IDR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Phapros | Jakarta | Salute | Prodotti farmaceutici | 255,36 Mrd IDR | -5,5x | 0,01 | 304 IDR | -2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Millennium Pharma | Jakarta | Salute | Prodotti farmaceutici | 169,44 Mrd IDR | 6,3x | -3,6 | 133 IDR | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |